HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

David E Gilham Selected Research

Neoplasm Metastasis (Metastasis)

10/2007Eotaxin-2 and colorectal cancer: a potential target for immune therapy.
6/2003Gene therapy of patient-derived T lymphocytes to target and eradicate colorectal hepatic metastases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


David E Gilham Research Topics

Disease

30Neoplasms (Cancer)
03/2023 - 06/2003
4B-Cell Lymphoma (Lymphoma, B Cell)
10/2018 - 07/2004
2Multiple Myeloma
03/2023 - 01/2019
2Myelodysplastic Syndromes (Myelodysplastic Syndrome)
03/2023 - 01/2019
2Hematologic Neoplasms (Hematological Malignancy)
01/2019 - 09/2013
2Ovarian Neoplasms (Ovarian Cancer)
10/2018 - 04/2018
2Renal Cell Carcinoma (Grawitz Tumor)
08/2014 - 05/2008
2Melanoma (Melanoma, Malignant)
10/2013 - 07/2008
2Colorectal Neoplasms (Colorectal Cancer)
10/2007 - 06/2003
2Neoplasm Metastasis (Metastasis)
10/2007 - 06/2003
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2019
1Hodgkin Disease (Hodgkin's Disease)
10/2018
1Lymphoma (Lymphomas)
10/2018
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
10/2018
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2014
1Graft vs Host Disease (Graft-Versus-Host Disease)
10/2013
1Breast Neoplasms (Breast Cancer)
05/2012
1Cytokine Release Syndrome
02/2011
1Non-Hodgkin Lymphoma (Lymphosarcoma)
05/2005

Drug/Important Bio-Agent (IBA)

12Chimeric Antigen ReceptorsIBA
03/2023 - 07/2012
6AntigensIBA
04/2018 - 07/2004
4LigandsIBA
03/2023 - 01/2017
4CytokinesIBA
10/2018 - 10/2007
4Proteins (Proteins, Gene)FDA Link
01/2018 - 10/2007
4CD19 AntigensIBA
01/2017 - 05/2005
3Interleukin-2 (IL2)IBA
08/2014 - 07/2008
3Carcinoembryonic AntigenIBA
10/2007 - 06/2003
2Neoplasm Antigens (Tumor Antigens)IBA
10/2019 - 04/2018
2Antigen Receptors (Antigen Receptor)IBA
01/2019 - 06/2003
2T-Cell Antigen Receptors (T-Cell Receptor)IBA
10/2013 - 07/2012
2VaccinesIBA
05/2012 - 07/2004
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
07/2008 - 05/2008
1NK Cell Lectin-Like Receptor Subfamily KIBA
03/2023
1HIV Protease InhibitorsIBA
01/2020
1Nelfinavir (Viracept)FDA Link
01/2020
1ImmunosorbentsIBA
10/2018
1EnzymesIBA
10/2018
1Interleukin-12 (IL 12)IBA
10/2018
1Natural Killer Cell ReceptorsIBA
08/2017
1Tyrosine Kinase InhibitorsIBA
08/2014
1pazopanibFDA Link
08/2014
1Sunitinib (Sutent)FDA Link
08/2014
1Interleukin-15 (Interleukin 15)IBA
10/2013
1Interleukin-7 (Interleukin 7)IBA
10/2013
1Peptides (Polypeptides)IBA
02/2011
1fludarabineIBA
05/2008
1Alkylating AgentsIBA
01/2008
1O(6)-Methylguanine-DNA MethyltransferaseIBA
01/2008
1Interleukin-13IBA
10/2007
1Interleukin-4 (Interleukin 4)IBA
10/2007
1ChemokinesIBA
10/2007
1Chemokine CCL24IBA
10/2007
1Chemokine ReceptorsIBA
10/2007
1Neural Cell Adhesion Molecules (Neural Cell Adhesion Molecule)IBA
05/2005
1Single-Chain AntibodiesIBA
05/2005
1Immunoglobulin Idiotypes (Idiotype, Immunoglobulin)IBA
07/2004

Therapy/Procedure

22Therapeutics
03/2023 - 06/2003
8Immunotherapy
01/2020 - 07/2004
3Drug Therapy (Chemotherapy)
07/2008 - 01/2008
2Cell- and Tissue-Based Therapy (Cell Therapy)
10/2013 - 06/2010